Global Ventricular Assist Device Market Size, Share & Trends Analysis Report (2020-2027) -

DUBLIN--()--The "Ventricular Assist Device Market Size, Share & Trends Analysis Report by Product (LVAD, RVAD, BiVAD, TAH), by Type of Flow (Pulsatile, Continuous), by Design, by Application, by Region, and Segment Forecasts, 2020 - 2027" report has been added to's offering.

The global ventricular assist device market size is expected to reach USD 4.1 billion by 2027, according to this report registering a CAGR of 11.7% over the forecast period.

Increase in prevalence of cardiovascular diseases such as congenital heart diseases, heart failure, hypertension, ventricular septal defect, and stroke due to rise in adoption of unhealthy lifestyle habits such as physical inactivity, smoking, and alcohol consumption drives the demand for ventricular assist devices (VADs).

Increase in global geriatric population, along with their susceptibility to cardiovascular diseases, is a major factor driving the market growth. According to estimates published by the United Nations in 2012, the global geriatric population was nearly 809.4 million and is expected to witness a twofold increase by 2050 with an estimated population of over 2,000 million. Geriatric population has a high risk of various cardiovascular diseases and a majority of them are expected to suffer from heart failure or stroke.

Moreover, the use of VADs as a bridge to transplant is gaining immense popularity due to improvements in device technology and reduction of VAD-associated complications. For instance, the United Kingdom National Health Service (UK NHS) financed a bridge-to-transplant (BTT) program in which left ventricular assist devices (LVADs) such as HeartMate II and HeartWare are used for treating patients.

Further key findings from the report suggest:

  • Left ventricular assist devices emerged as the largest product segment in 2019 with a share of 76.9% in the global ventricular assist device market. This is attributed to the increasing demand for LVADs in bridge-to-transplantation for patients suffering from end-stage heart failure
  • On the basis of type of flow, continuous flow accounted for the largest share in 2019, and is further projected to register the highest CAGR over the forecast period as these devices require low maintenance and replacement
  • Implantable VAD emerged as the leading design type segment in 2019 owing to the increasing preference for long-term treatment methods
  • Destination therapy is expected to register a significant growth rate over the forecast period owing to the increasing instances of cardiovascular diseases
  • North America dominated the global VAD market in 2019 owing to the presence of majority of the global obese population, which is one of the key factors leading to the rise in cardiovascular diseases

Key Topics Covered:

1. Research Methodology & Scope

2. Executive Summary

3. Ventricular Assist Device Market Variables, Trends & Scope

3.1 Market Lineage Outlook

3.1.1 Parent market analysis

3.1.2 Ancillary market analysis

3.2 Penetration & Growth Prospect Mapping

3.3 Pricing Analysis

3.4 Product Pipeline Analysis

3.5 Industry Analysis

3.5.1 Consumer behavior analysis

3.5.2 Market influencer analysis

3.5.3 List of key end users, by product

3.6 Technology Timeline Overview

3.6.1 Technology timeline ventricular assist device market changing technology & adoption

3.7 Regulatory Framework

3.7.1 Reimbursement framework

3.7.2 Standards & compliance CPT Coding implications HCPCS Coding implications ICD-10-CM Coding implications

3.7.3 Safety

3.8 Ventricular Assist Device Market Dynamics

3.8.1 Market driver analysis Increasing prevalence of cardiovascular diseases Technological advancements pertaining to novel product development Shortage of transplant organs

3.8.2 Market restraint analysis High procedure cost Insurance coverage is limited in emerging countries

3.8.3 Industry challenges Development of small, affordable and efficient devices

3.9 Ventricular Assist Device Market Analysis Tools

3.9.1 Industry analysis - Porter's

3.9.2 PESTEL analysis

3.9.3 Major deals & strategic alliances analysis

3.9.4 Partnerships & collaborations

3.9.5 Case study

4. Ventricular Assist Device Market: Competitive Analysis

4.1 Market Participation Categorization

4.1.1 Regional network map

4.1.2 Innovators

4.1.3 Market leaders

4.1.4 Key company market share analysis, 2018 Abbott Abiomed

4.1.5 Company market share by region, 2018

4.2 Public Companies

4.2.1 Company market position analysis

4.2.2 Heat map analysis

4.3 Private Companies

4.3.1 List of emerging companies in VAD market space

4.3.2 Heat map analysis

4.4 Vendor Landscape

4.4.1 List of key distributors and channel partners

4.4.2 Key customers

4.4.3 Funding outlook

5. Ventricular Assist Device Market: Product Estimates & Trend Analysis

5.1 Definitions & Scope

5.2 Global Ventricular Assist Devices Market: Product Market Share Analysis, 2019 and 2027

5.3 Left ventricular assist devices

5.4 Right ventricular assist devices

5.5 Bi-ventricular assist devices

5.6 Total artificial heart

6. Ventricular Assist Device Market: Type Of Flow Estimates & Trend Analysis

6.1 Definitions & Scope

6.2 Global Ventricular Assist Devices Market: Type of Flow Market Share Analysis, 2019 and 2027

6.3 Pulsatile flow

6.4 Continuous flow

7. Ventricular Assist Device Market: Design Estimates & Trend Analysis

7.1 Definitions & Scope

7.2 Global Ventricular Assist Devices Market: Design Market Share Analysis, 2019 and 2027

7.3 ImplanTable ventricular assist devices

7.4 Transcutaneous ventricular assist devices

8. Ventricular Assist Device Market: Application Estimates & Trend Analysis

8.1 Definitions & Scope

8.2 Global Ventricular Assist Devices Market: Application Market Share Analysis, 2019 and 2027

8.3 Bridge to transplantation

8.4 Destination therapy

8.5 Bridge to recovery & Bridge to candidacy

9. Ventricular Assist Device Market: Regional Estimates & Trend Analysis, By Product, Type Of Flow, Design & Application

9.1 Global Ventricular assist devices Market: Regional Movement Analysis

9.2 North America

9.3 Europe

9.4 Asia Pacific

9.5 Latin America

9.6 MEA

9.7 SWOT Analysis, by Region

10. Company Profiles

10.1 Abiomed

10.1.1 Company overview

10.1.2 Financial performance

10.1.3 Product benchmarking

10.1.4 Strategic initiatives

10.2 Medtronic

10.3 Abbott

10.4 Berlin Heart

10.5 Cardiac Assist, Inc.

10.6 Jarvik Heart, Inc.

10.7 ReliantHeart, Inc.

10.8 Sun Medical Technology Research Corp.

10.9 KOL Commentary

For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900